Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Sep 28 · above the Ichimoku cloud · RSI 47 · MACD below its signal
| 2.41 | 52-week high | +18.14% |
| 2.38 | Previous week high | +16.42% |
| 2.27 | Previous month high | +11.27% |
| 2.13 | Previous week low | +4.66% |
| 2.13 | R3 (classic) | +4.49% |
| 2.11 | R2 (classic) | +3.59% |
| 2.10 | Previous day high | +2.70% |
| 2.08 | R1 (classic) | +1.80% |
| 2.06 | Pivot | +0.90% |
| 2.04 | Price now | |
| 2.04 | Previous day low | −0.00% |
| 2.02 | S1 (classic) | −0.90% |
| 2.00 | S2 (classic) | −1.80% |
| 1.97 | S3 (classic) | −3.59% |
| 1.78 | Previous month low | −12.75% |
| 1.55 | 52-week low | −24.02% |
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $1.6M | 0.00% | 985.50K | +0.9% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SEER trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 17, 2026 | Horn David R.President | Sale at price 2.03 per share. | 7.3K | $14.81K |
| Jul 27, 2026 | Langer Robert S Jr.Director | Stock Award(Grant) at price 0.00 per share. | 16.5K | — |
| Jul 27, 2026 | Roelofs Nicolas HDirector | Stock Award(Grant) at price 0.00 per share. | 16.5K | — |
| Jul 27, 2026 | Nishar DipchandDirector | Stock Award(Grant) at price 0.00 per share. | 16.5K | — |
| Jul 27, 2026 | Mcguire Terrance GDirector | Stock Award(Grant) at price 0.00 per share. | 16.5K | — |
| Jul 27, 2026 | Ro IsaacDirector | Stock Award(Grant) at price 0.00 per share. | 12.4K | — |
| Jul 27, 2026 | Gulyani MeetaDirector | Stock Award(Grant) at price 0.00 per share. | 16.5K | — |
| Jul 7, 2026 | Nishar DipchandDirector | Sale at price 2.18 per share. | 10.7K | $23.27K |
| May 19, 2026 | Horn David R.Chief Executive Officer | Sale at price 1.69 per share. | 7.3K | $12.35K |
| May 7, 2026 | Bazarko Anthony R.Officer | Stock Award(Grant) at price 0.00 per share. | 75K | — |
| Feb 17, 2026 | Farokhzad OmidChief Executive Officer | Sale at price 1.99 per share. | 24.4K | $48.65K |
| Feb 17, 2026 | Horn David R.President | Sale at price 1.99 per share. | 7.7K | $15.45K |
| Feb 2, 2026 | Farokhzad OmidChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 697.2K | — |
| Feb 2, 2026 | Horn David R.President | Stock Award(Grant) at price 0.00 per share. | 79K | — |
| Dec 8, 2025 | Farokhzad OmidChief Executive Officer | — | 3.56M | — |
| Dec 8, 2025 | Mcguire Terrance GDirector | — | 4.1K | — |
| Nov 18, 2025 | Farokhzad OmidChief Executive Officer | Sale at price 1.97 per share. | 33.8K | $66.71K |
| Nov 18, 2025 | Horn David R.President | Sale at price 1.97 per share. | 6.8K | $13.40K |
| Sep 1, 2025 | Ro IsaacDirector | Stock Award(Grant) at price 0.00 per share. | 41K | — |
| Aug 19, 2025 | Farokhzad OmidChief Executive Officer | Sale at price 2.04 per share. | 34K | $69.48K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.5 | -5.5 | -2.3 | 16.1 | -4.1 | -11.2 | 33.7 | -11.7 | 13.8 | -8.5 | +11.5% | ||
| 2025 | 3.5 | -12.1 | -19.5 | 17.8 | -3.5 | 11.5 | -0.9 | -3.3 | 5.9 | 1.8 | -13.1 | -4.7 | −20.8% |
| 2024 | -11.3 | 5.8 | 4.4 | 9.5 | -13.5 | -6.7 | 17.9 | -15.2 | 17.3 | -3.6 | 30.0 | -6.5 | +19.1% |
| 2023 | -21.6 | -10.1 | -5.6 | -13.5 | 10.2 | 16.0 | 18.5 | -48.0 | -16.0 | -25.8 | -1.8 | 20.5 | −66.6% |
| 2022 | -31.0 | -2.6 | -0.5 | -52.2 | 22.0 | 0.8 | 0.6 | 12.2 | -23.4 | 1.2 | -17.5 | -10.2 | −74.6% |
| 2021 | 11.2 | -22.7 | 3.7 | 1.8 | -41.9 | 10.8 | -2.6 | 25.2 | -13.6 | 6.9 | -39.6 | 2.2 | −59.4% |
| 2020 | — |
Buy / hold / sell counts
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.